Korean Circ J.  1974 Jun;4(1):57-63. 10.4070/kcj.1974.4.1.57.

Antihypertensive Effect of Debrisoquin Sulfate in the Treatment of Hypertension

• Song HS
• Lee JI
• Park HM
• Lee CH
• Suh SK

• KMID: 2229711
• DOI: http://doi.org/10.4070/kcj.1974.4.1.57

Abstract

Authors observed the antihypertensive effect of debrisoquin sulfate in 35 cases of essential hypertension and following results were obtained. 1) Results of short term control of blood pressure with debrisquin in 35 hypertensive patients revealed good control in 74.3%, fair in 14.3%, poor in 5.7% and failure in 5.7% of cases. Significant reduction of blood pressure was achieved in 7 of 9 cases of hypertension with addition of hydrochlorthiazide to debrisoquin. 2) During long term therapy with debrisoquin (duration of average 3.9 months), good control cases were slightly reduced(good in 58.6%, fair in 24.1%, poor in 6.9%, failure in 10.3%). But average effective dose of debriioquin was not increased significantly. 3) Antihypertensive effect of debrisoquin was slightly reduced in the cases of severe hypertension, hypertension of over 10 years duration and complication of cerebrovascular accident. 4) The side effects during treatment with debrisoquin were dizziness in 31.4%, headache in 11.4%, dry mouth, blurred vision, general weakness, insomnia in 8.6% respectively. There were no side effects in 48.6% of cases.

MeSH Terms

Blood Pressure
Debrisoquin*
Dizziness
Headache
Humans
Hypertension*
Mouth
Sleep Initiation and Maintenance Disorders
Stroke
Debrisoquin

Reference

1). Moe R.A.., Bates H.M.., Palkoskisi Z.M.., Banziger R.Cardiovascular effects of 3,4-dihydro-2ClH) iscquincline carboxaniichneᄂDeciina: c~). Curr. Therap. Res. 6:299. 1964.

2). Luria M.H.., Pre is E.D.Treaime/it of hypertension with debrisquin sulfate Declinax'). Curr. Therap. Re.s. 7:289.

3). 朴招仁. 못堅ᅳ, 車ή 1ΓΜ f 에서DebHSo- 위«•«의임상적효괴57. 1974.

4). 高英博. 張麟, 李抑ΓΓ IXhHquine 降壓効果에관한臨床的觀察. ᄎ韓两科學會雜誌. 17:278. 1974.

5). Friedberg C.K.Diseases of the Heart. 3rd ed.W.B. Saunders;1966.

6). Athanassiadis EX. Cranston, W.I., Juel-Jensen, B. E. and Oliver, D.O.: Clinical observations on the effects of debrisoquine sulphate in patients zvith high blood-pressure. Brit. Med. J. 2:732. 1966.

7). Abrams W.B.., Moe R.A.., Bates H.., Wallen M.., Odze M.., Crow A.., Pocelinko R.Adrenergic mechanisms in the treatment of essential hypertension. Am. J. Cardiol. 12:711. 1963.

8). Pocelinko R.., Abramsi W.B.Hemodynamic and renal studies with isocaramidine sulfate. J. Newark City Hospt. 1:57. 1964.

9). Kitchin A.H.., Turner R.W.D.Studies on debrisoquine sulphate. Brit. Med. J. 24:728. 1966.

10). Blechman M.Sokol, C ond Moser, M.: DcbrHoquin sulfate: A clinical cvalvation of a new antihypertensive agent. Cur?'. Therap. Res. 11:71. 1969.

11). Firmerty F.A. Jr.Nezver antlhype?-tensivc drugs. Med. Clin. North Am. 48:329. 1964.

12). Orgain E.S.., Kern Α.Debrisoquin in the therapy of hypertension. Arch. Int. Med. 125:255. 1970.

13). Bryant J.M.., Fletcher L. Jr.., Schvartz N.Fertig, H. and Quan, B.F.: The role of postganglionic sympathetic blockade in antihypertensive therapy. J.A.M.A. 193:1021. 1965.

14). Rosendorff C.., Marsden C.D.., Cranston W. I.Clinical evaluation of debrisᄋquin in the treatment of hypertension. Arch. Int. Med. 122:487. 1968.